Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05700916Phase 1Active, not recruiting
Phase 1, randomised, double-blind trial in dyslipidemia and obesity (2 arms), sponsored by University of Connecticut. Primary endpoint: Serum LDL Cholesterol at 8 weeks. Started Oct 2023; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05700916.